Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
Description
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment
